The sound of silence: A proxy for platinum toxicity

Journal of Clinical Oncology

Volumn 34, Issue 23, 2016, Pages 2687-2689

  Oldenburg, Jan ^a,b   Gietema, Jourik A ^c  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; VINBLASTINE; PLATINUM;

ADVERSE DRUG REACTION; CANCER CHEMOTHERAPY; EDITORIAL; HEARING IMPAIRMENT; HUMAN; HYPERTENSION; LEUKEMIA; MALIGNANT NEOPLASTIC DISEASE; NEUROTOXICITY; OTOTOXICITY; PRIORITY JOURNAL; QUALITY OF LIFE; LIVING WILL; SOUND;

ADVANCE DIRECTIVES; HUMANS; PLATINUM; SOUND;

EID: 84981244453     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.68.2476     Document Type: Editorial

References (30)

1. Frisina RD, Wheeler HE, Fossa SD, et al: Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer. J Clin Oncol 34:2712-2720, 2016
2. Hanna N, Einhorn LH: Testicular cancer: A reflection on 50 years of discovery. J Clin Oncol 32:3085-3092, 2014
3. Einhorn LH: Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 41: 3275-3280, 1981
4. Travis LB, Beard C, Allan JM, et al: Testicular cancer survivorship: Research strategies and recommendations. J Natl Cancer Inst 102:1114-1130, 2010
5. Bajorin DF: The graying of testis cancer patients: What have we learned? J Clin Oncol 25:4341-4343, 2007
6. Brydøy M, Oldenburg J, Klepp O, et al: Observational study of prevalence of long-Term Raynaud-like phenomena and neurological side effects in testicular cancer survivors. J Natl Cancer Inst 101:1682-1695, 2009
7. Feldman DR, Bosl GJ, Sheinfeld J, et al: Medical treatment of advanced testicular cancer. JAMA 299:672-684, 2008
8. Oldenburg J, Fossa SD, Nuver J, et al: Testicular seminoma and nonseminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24:vi125-vi132, 2013 (suppl 6)
9. Sprauten M, Brydøy M, Haugnes HS, et al: Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a populationbased sample of long-Term testicular cancer survivors. J Clin Oncol 32:571-578, 2014
10. Theunissen EA, Dreschler WA, Latenstein MN, et al: A new grading system for ototoxicity in adults. Ann Otol Rhinol Laryngol 123:711-718, 2014
11. Jensen K: Measuring side effects after radiotherapy for pharynx cancer. Acta Oncol 46:1051-1063, 2007
12. Przewoźny T, Gó jska-Grymajlo A, Kwarciany M, et al: Hypertension is associated with dysfunction of both peripheral and central auditory system. J Hypertens 34:736-744, 2016
13. Haugnes HS, Aass N, Fossa SD, et al: Components of the metabolic syndrome in long-Term survivors of testicular cancer. Ann Oncol 18:241-248, 2007
14. Sprauten M, Darrah TH, Peterson DR, et al: Impact of long-Term serum platinum concentrations on neuro-And ototoxicity in cisplatin-Treated survivors of testicular cancer. J Clin Oncol 30:300-307, 2012
15. Oldenburg J, Fossa SD, Dahl AA: Scale for chemotherapy-induced longterm neurotoxicity (SCIN): Psychometrics, validation, and findings in a large sample of testicular cancer survivors. Qual Life Res 15:791-800, 2006
16. Boer H, Proost JH, Nuver J, et al: Long-Term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors. Ann Oncol 26:2305-2310, 2015
17. Nichols CR, Roth B, Albers P, et al: Active surveillance is the preferred approach to clinical stage I testicular cancer. J Clin Oncol 31:3490-3493, 2013
18. Oldenburg J, Aparicio J, Beyer J, et al: Personalizing, not patronizing: The case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Ann Oncol 26:833-838, 2015
19. Loehrer PJ Sr, Johnson D, Elson P, et al: Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: An Eastern Cooperative Oncology Group trial. J Clin Oncol 13:470-476, 1995
20. Culine S, Kerbrat P, Kramar A, et al: Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: A randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP). Ann Oncol 18:917-924, 2007
21. Kondagunta GV, Bacik J, Bajorin D, et al: Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors. J Clin Oncol 23:9290-9294, 2005
22. Haugnes HS, Aass N, Fossa SD, et al: Pulmonary function in long-Term survivors of testicular cancer. J Clin Oncol 27:2779-2786, 2009
23. Haugnes HS, Bosl GJ, Boer H, et al: Long-Term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol 30: 3752-3763, 2012
24. Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germcell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316:1435-1440, 1987
25. Fleer J, Hoekstra HJ, Sleijfer DT, et al: Quality of life of testicular cancer survivors and the relationship with sociodemographics, cancer-related variables, and life events. Support Care Cancer 14:251-259, 2006
26. Joly F, Hé ron JF, Kalusinski L, et al: Quality of life in long-Term survivors of testicular cancer: A population-based case-control study. J Clin Oncol 20:73-80, 2002
27. Kim C, McGlynn KA, McCorkle R, et al: Quality of life among testicular cancer survivors: A case-control study in the United States. Qual Life Res 20: 1629-1637, 2011
28. Oldenburg J, Kraggerud SM, Cvancarova M, et al: Cisplatin-induced longterm hearing impairment is associated with specific glutathione s-Transferase genotypes in testicular cancer survivors. J Clin Oncol 25:708-714, 2007
29. Oldenburg J, Fossa SD, Ikdahl T: Genetic variants associated with cisplatininduced ototoxicity. Pharmacogenomics 9:1521-1530, 2008
30. Schacht J, Talaska AE, Rybak LP: Cisplatin and aminoglycoside antibiotics: Hearing loss and its prevention. Anat Rec (Hoboken) 295:1837-1850, 2012